Gene Therapy Supply Runs Out, Company Warns of Treatment Delays

(MedPage Today) — Etranacogene dezaparvovec (Hemgenix), the only commercially available gene therapy for hemophilia B, is temporarily unavailable, according to maker CSL Behring.
In a letter addressed to the hemophilia B community, the company…